3rd Quarter - Termination

PODESTA GROUP, INC. for HUMAN LONGEVITY, INC.

Firm
Client
Income
$40,000
Expenses
—
Terminated
Sep 6, 2017

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

NIH and FDA funding.

LobbyistCovered position, as disclosed
ELIZABETH A INADOMI —
MATTHEW LEE JOHNSON —
ANTHONY PODESTA —
ANNA KATHERINE WEINSTEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Healthcare and biotechnology. Genetic non-discrimination. Regulation of diagnostic tests.

LobbyistCovered position, as disclosed
ELIZABETH A INADOMI —
MATTHEW LEE JOHNSON —
ANTHONY PODESTA —
ANNA KATHERINE WEINSTEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Genomics and computing.

LobbyistCovered position, as disclosed
ELIZABETH A INADOMI —
MATTHEW LEE JOHNSON —
ANTHONY PODESTA —
ANNA KATHERINE WEINSTEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.